Patent application number | Description | Published |
20100003259 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 01-07-2010 |
20100040624 | Human Tumor Necrosis Factor TR21 and Methods Based Thereon - The present invention relates to TR21 polypeptides. In particular, isolated nucleic acid molecules are provided encoding human TR21 protein. TR21 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TR21 activity. | 02-18-2010 |
20100111953 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 05-06-2010 |
20110117093 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 05-19-2011 |
20110293610 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 12-01-2011 |
20120058119 | HUMAN TUMOR NECROSIS FACTOR TR21 AND METHODS BASED THEREON - The present invention relates to TR21 polypeptides. In particular, isolated nucleic acid molecules are provided encoding human TR21 protein. TR21 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TR21 activity. | 03-08-2012 |
20120121606 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 05-17-2012 |
20120213781 | Monovalent and Multivalent Multispecific Complexes and Uses Thereof - Monovalent and multivalent multispecific complexes including ELP-MRD fusion proteins containing one or more modular recognition domains (MRDs) that bind target antigens are described. The use of these monovalent and multivalent multispecific complexes (e.g., ELP-MRD fusion proteins) in diagnostic, prognostic, and therapeutic applications and methods of making these complexes are also described. | 08-23-2012 |
Patent application number | Description | Published |
20100291081 | RAGE FUSION PROTEINS - The present invention provides novel therapeutics and methods of treatment for diseases associated with activation of the advanced glycation endproducts receptor (RAGE). | 11-18-2010 |
20110182887 | HUMANIZED ANTI-CD22 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE - The present invention provides chimeric and humanized versions of anti-CD22 mouse monoclonal antibody, HB22.7. The anti-CD22 antibodies of the invention comprise four human or humanized framework regions of the immunoglobulin heavy chain variable region (“VH”) and four human or humanized framework regions of the immunoglobulin light chain variable region (“VK”). The invention further comprises heavy and/or light chain FW regions that contain one or more backmutations in which a human FW residue is exchanged for the corresponding residue present in the parental mouse heavy or light chain. Human or humanized VH framework regions of antibodies of the invention may comprise one or more of the following residues: a valine (V) at position 24 of framework region 1, a glycine (G) at position 49 of framework region 2, and an asparagine (N) at position 73 of framework region 3, numbered according to Kabat. The invention further relates to pharmaceutical compositions, immunotherapeutic compositions, and methods using therapeutic antibodies that bind to the human CD22 antigen and that preferably mediate human ADCC, CDC, and/or apoptosis for: the treatment of B cell diseases and disorders in human subjects, such as, but not limited to, B cell malignancies, for the treatment and prevention of autoimmune disease, and for the treatment and prevention of graft-versus-host disease (GVHD), humoral rejection, and post-transplantation lymphoproliferative disorder in human transplant recipients. | 07-28-2011 |
20120100166 | Ang-2 Binding Complexes and Uses Thereof - Complexes containing one or more modular recognition domains (MRDs) and MRDs attached to scaffolds including antibodies are described. The manufacture of these complexes are the use of these complexes to treat and diagnose diseases and disorders are also described. | 04-26-2012 |
20130177560 | METHODS OF TREATMENT USING RAGE FUSION PROTEINS - The present invention provides novel therapeutics and methods of treatment for diseases associated with activation of the advanced glycatioπ endproducts receptor (RAGE). | 07-11-2013 |
20130259868 | Ang-2 Binding Complexes and Uses Thereof - Complexes containing one or more modular recognition domains (MRDs) and MRDs attached to scaffold's including antibodies are described. The manufacture of these complexes are the use of these complexes to treat and diagnose diseases and disorders are also described. | 10-03-2013 |
20140065142 | Multivalent and Monovalent Multispecific Complexes and Their Uses - Compositions containing multivalent and monovalent multispecific complexes having scaffolds such as antibodies that support such binding functionalities are described. The use of and methods of compositions containing multivalent and monovalent multispecific complexes having scaffolds, such as antibodies, that support such binding functionalities are also described. | 03-06-2014 |
20140088019 | Monovalent and Multivalent Multispecific Complexes and Uses Thereof - Monovalent and multivalent multispecific complexes including ELP-MRD fusion proteins containing one or more modular recognition domains (MRDs) that bind target antigens are described. The use of these monovalent and multivalent multispecific complexes (e.g., ELP-MRD fusion proteins) in diagnostic, prognostic, and therapeutic applications and methods of making these complexes are also described. | 03-27-2014 |
Patent application number | Description | Published |
20080233174 | HIGH DOSE FILM COMPOSITIONS AND METHODS OF PREPARATION - This invention relates to films incorporating high amounts of pharmaceutical agents and methods for the preparation of the same. Moreover, the invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films contain a pharmaceutical and/or cosmetic active agent with no more than a 10% variance of the active agent pharmaceutical and/or cosmetic active agent per unit area of the film. | 09-25-2008 |
20090104270 | Film delivery system for tetrahydrolipstatin - The present invention includes a pharmaceutical-based film system which includes various small-scale forms of pharmaceutically active agents, including tetrahydrolipstatin, in a film base. Such forms include nanoparticles, microparticles, and combinations thereof. Methods of producing such film and providing a dosage of the pharmaceutical in a film are also provided. | 04-23-2009 |
20110033542 | SUBLINGUAL AND BUCCAL FILM COMPOSITIONS - The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent. | 02-10-2011 |
20130035378 | FILM DELIVERY SYSTEM FOR TETRAHYDROLIPSTATIN - The present invention includes a pharmaceutical-based film system which includes various small-scale forms of pharmaceutically active agents, including tetrahydrolipstatin, in a film base. Such forms include nanoparticles, microparticles, and combinations thereof. Methods of producing such film and providing a dosage of the pharmaceutical in a film are also provided | 02-07-2013 |
Patent application number | Description | Published |
20090291757 | SYSTEMS, METHODS, AND APPARATUS FOR CONTROLLING A GAMING MACHINE DISPLAY - A gaming machine is provided including a display unit configured to generate video images, an input unit, an ambient light sensor, and a controller coupled to the display unit, input unit, and ambient light sensor. The controller is configured to receive physical characteristics of a player via the input unit, determine an ambient light level of an environment of the gaming machine based on a signal generated by the ambient light sensor, determine a desired brightness level for video images based on the determined ambient light level, determine a desired contrast level for the video images based on the received physical characteristics or the determined ambient light level, generate display settings for the video images based on the determined brightness level and the determined contrast level, and display the graphics to the player via the display unit using the generated display settings. | 11-26-2009 |
20100120484 | GAMING SYSTEM, GAMING DEVICE AND METHOD PROVIDING A GROUP OF TIMED GAMES - The gaming system, gaming device and gaming method provides a plurality of sequential player events in which the player must take an action in a designated period of time and where the player has less time to take the action in each subsequent event. | 05-13-2010 |
20100120506 | GAMING DEVICE AND METHOD OF PROVIDING AN ADJUSTED PAYTABLE FOR A NUMBER OF FUTURE PLAYS OF A GAME - One embodiment of the present disclosure provides a game operable upon a wager by a player which initially employs an initial or default paytable. The gaming device enables a player to place wagers on plays of the game. The gaming device displays the game outcomes and provides the player with any awards based on the game outcomes in accordance with the default paytable. Upon an occurrence of a triggering event, a bonus mode is triggered. In one embodiment, when the bonus mode is triggered, the gaming device offers to replace the default paytable with a different one of the paytables for a limited number of future plays of the game, if the player agrees to make an additional wager on each of those future plays of the game. If the player chooses to accept the offer, the gaming device determines outcomes and provides any awards for the limited number of future plays in accordance with the new paytable, as long as the player continues placing the additional wager for each of those plays. If the player chooses not to accept the offer to replace the default paytable with a new paytable, the gaming device displays the number of future plays of the game without requiring the additional wager and provides any awards for those plays in accordance with the default paytable. | 05-13-2010 |
20130203490 | System and Method for Cross Platform Persistent Gaming Sessions Using a Mobile Device - Various embodiments directed to systems and methods that enable cross platform persistent gaming sessions using a mobile device in a mobile device-enhanced system are disclosed herein. In one embodiment, a method for reformatting original graphical content designed for presentation on a gaming machine for presentation on a mobile computing device for which the original graphical content was not originally designed may include transmitting display information associated with a display on the mobile computing device to the gaming machine. The method may include receiving, by the gaming machine, the display information transmitted by the mobile computing device. The method may include determining a resolution or aspect ratio associated with the original graphical content. The method may include reformatting the original graphical content based on the resolution or aspect ratio associated with the original graphical content and the display information received from the mobile computing device. | 08-08-2013 |
20130274007 | DEMOGRAPHIC ADAPTATION SYSTEM AND METHOD - Various systems, gaming devices, and methods for demographic adaptation are disclosed herein. In one embodiment, a method for modifying a gaming presentation includes presenting a gaming presentation on a computing device. The method further includes using a biometric image capture device to obtain biometric information of a user. The method further includes determining the age of the user based upon the obtained biometric information. The method further includes modifying the gaming presentation by altering sensory information based upon the determined age of the user. | 10-17-2013 |
20140235320 | DYNAMIC PALPABLE CONTROLS FOR A GAMING DEVICE - Disclosed is a gaming machine touch screen system incorporating a flat transparent or nearly transparent layer that contains a series of active elements/actuators/chambers that enable a vertical displacement of the touch screen top surface. These active elements displace the top surface of the touch screen upon command of the gaming machine to provide features perceptible to the player's touch. | 08-21-2014 |
20140323191 | GAMING SYSTEM, GAMING DEVICE AND METHOD PROVIDING A GROUP OF TIMED GAMES - The gaming system, gaming device and gaming method provides a plurality of sequential player events in which the player must take an action in a designated period of time and where the player has less time to take the action in each subsequent event. | 10-30-2014 |
Patent application number | Description | Published |
20130217491 | VIRTUAL BUTTON DECK WITH SENSORY FEEDBACK - Various embodiments are directed to systems and methods for providing sensory feedback on a virtual button deck, or more generally, to systems and methods for providing sensory feedback on a touch device associated with a gaming machine. For example, a gaming machine may include a display for presenting a primary game to a player. The gaming machine may include one or more player input devices for receiving player input. At least one of the one or more player input devices may be a touch screen display having a touch surface having a first side and a second side. The touch screen display may be configured to provide audio feedback to a player by emanating audio from the touch surface. | 08-22-2013 |
20140094256 | Apparatus, System and Method for Presenting Different Wagering Games for Concurrent Play - Apparatus, methods and systems are set forth to enable a player to play several, different concurrent games at a gaming device. The player selects the games to play from a game library and a processor assigns the game instances to real estate at the gaming device display. The player may record wagers to play the games. A processor determines game cycle times and choreographs play of the games' start and stop cycles to provide an appealing and serial display of game outcomes to the player. | 04-03-2014 |
20140302932 | Adaptive Game Audio - Disclosed are a system and method wherein a gaming machine samples the ambient sound environment and performs a time to frequency conversion to create an ambient sound profile. Profiles of alternate sounds for emission by the gaming machine are compared to the ambient profile and the sound most likely to minimize ambient noise masking is selected for use. | 10-09-2014 |
20140329581 | Method for Operating a Cooperative Game - A cooperative/competitive gaming system includes a plurality of gaming machines, a bonus server and a network for coupling the plurality of gaming machines to the bonus server. A method for operating a cooperative/competitive game includes providing two or more pools having respective levels. Two or more players are permitted to form groups. The groups are allowed to play for pool levels based on the number of players in the group. | 11-06-2014 |
20140353983 | Electronic Locking Mechanism - An electronic lock and system particularly for replacing existing mechanical locks for gaming devices are disclosed herein. According to one embodiment, the gaming device includes a cabinet having a chassis and a main gaming device door locked by a mechanical lock. The electronic lock is configured to have a profile to replace the existing mechanical locks and includes a rotatable bolt receiving a sleeve. In a retained and locked position the sleeve is within the lock barrel and an operator is nested in a pocket in the barrel head. Upon receiving a command a motor rotates a cam and the sleeve is released to axially move to release the operator from the pocket for rotation of the sleeve and bolt to unlock the door. Sensors sense for fault conditions. Authentication is required to provoke the opening command Opening events may be logged at a system server or local memory. | 12-04-2014 |
20150133219 | Systems and Methods for Providing Control of a Wagering Device Using a Smartphone or Mobile Device - Gaming systems and methods are set forth for players to link a player mobile communication device such as a Smart phone to a gaming terminal to present at the player mobile communication device display an auxiliary or substitute player interface for controlling the game. | 05-14-2015 |
Patent application number | Description | Published |
20080314797 | Integrated hydroprocessing with high productivity catalysts - Integrated hydroprocessing methods using high activity, low density catalysts are provided. The high activity catalysts allow for lower temperature operation, which reduces catalyst degradation, while the low density of the catalysts means a corresponding reduction in the amount of metal needed to fill a reactor volume. The methods allow for flexible processing of feedstocks with a variety of wax contents. | 12-25-2008 |
20090005627 | Integrated hydroprocessing with high productivity catalysts - Integrated hydroprocessing methods using high activity, low density catalysts are provided. The high activity catalysts allow for blocked operation when processing lube range feedstocks of widely varying characteristics, such as wax content, without having to substantially change the configuration or operating conditions of the process train. Instead, the different feedstocks can be accommodated by varying the reaction temperature in the process train. | 01-01-2009 |
20090166251 | All catalytic medicinal white oil production - All catalytic process for producing white oils is provided. More particularly, medicinal grade white oils are produced from a process including hydrotreating and/or hydrocracking, catalytic dewaxing followed by hydrofinishing to produce a medicinal white oil. | 07-02-2009 |
20100176027 | Sour service hydroprocessing for diesel fuel production - An integrated process for producing diesel fuel from feedstocks, including diesel fuel production under sour conditions, is provided. The ability to process feedstocks under higher sulfur and/or nitrogen conditions allows for reduced cost processing and increases the flexibility in selecting a suitable feedstock. In addition to the benefits in sour service, the process also returns to clean service activity levels more quickly. | 07-15-2010 |
20110056869 | FUEL PRODUCTION FROM FEEDSTOCK CONTAINING LIPIDIC MATERIAL - This invention relates to the production of dewaxed and/or hydroisomerized fuel composition that includes a step of hydrotreating a feedstock containing the lipidic material. The fuel compositions are high quality fuel compositions in which the fuel can be ultimately tailored for a variety of end uses such as jet fuel or diesel fuel. | 03-10-2011 |
20110132803 | TWO STAGE HYDROPROCESSING WITH DIVIDED WALL COLUMN FRACTIONATOR - A divided wall column allows for fractionation of multiple streams while maintaining separate product qualities. Effluents from multiple stages of a reaction system can be processed in a single divided wall column. The divided wall column can produce multiple cuts from each separated area, as well as at least one output from a common area. | 06-09-2011 |
20110163009 | HYDROPROCESSING OF HIGH NITROGEN FEED USING BULK CATALYST - Methods are provided for hydrotreating high nitrogen feeds with improved results for nitrogen removal, aromatic saturation, and/or sulfur removal. The method includes hydrotreating the feed with a supported hydrotreating catalyst followed by a bulk metal catalyst, the hydrotreated effluent of which can be suitable for use as a feed to an FCC reactor. | 07-07-2011 |
20110219669 | Hydroprocessing of diesel range biomolecules - Non-hydrotreated biocomponent feeds can be mixed with mineral feeds and processed under catalytic isomerization/dewaxing conditions. The catalytic isomerization/dewaxing conditions can be selected to advantageously also substantially deoxygenate the mixed feed. Diesel fuel products with improved cold flow properties can be produced. | 09-15-2011 |
20110219671 | DEWAXING OF RENEWABLE DIESEL FUEL - Feeds containing a hydrotreated biocomponent portion, and optionally a mineral portion, can be processed under catalytic conditions for isomerization and/or dewaxing. The sulfur content of the feed for dewaxing can be selected based on the hydrogenation metal used for the catalyst. Diesel fuel products with improved cold flow properties can be produced. | 09-15-2011 |
20110219672 | HYDROPROCESSING OF BIODIESEL FUELS AND BLENDS - A method for producing diesel fuel from biocomponent feeds includes hydrotreating the feed followed by catalytic dewaxing with a ZSM-48 containing catalyst. The hydrotreated feed may be cascaded directly to the dewaxing step, or the hydrotreated feed can undergo intermediate separation. The diesel fuel resulting from processing of the biocomponent feed exhibits superior cetane values. | 09-15-2011 |
20110259793 | Low pressure production of low cloud point diesel - A diesel fuel product with beneficial cold flow properties can be produced. A suitable feedstock for forming a diesel boiling range product can be hydrotreated to have a sulfur content of at least about 100 wppm and then dewaxed. This two stage process can allow for production of an arctic or winter diesel without use of high pressures. Optionally, a divided wall column fractionator can be used to allow a single separation stage to handle the effluent from both the hydroprocessing and the dewaxing stages. | 10-27-2011 |
20120080357 | HYDROCRACKING PROCESS SELECTIVE FOR IMPROVED DISTILLATE AND IMPROVED LUBE YIELD AND PROPERTIES - This invention relates to a process involving hydrocracking of a feedstream in which a converted fraction can exhibit relatively high distillate product yields and maintained or improved distillate fuel properties, while an unconverted fraction can exhibit improved properties particularly useful in the lubricant area. | 04-05-2012 |
20130130893 | ACTIVATION OF DUAL CATALYST SYSTEMS - Methods are provided for liquid phase activation of dewaxing and/or hydrofinishing catalysts that include a molecular sieve or other acidic crystalline support. The methods are compatible with activating the catalysts as part of a catalyst system that also includes a hydrotreating catalyst. | 05-23-2013 |
20140048448 | HYDROPROCESSING OF HIGH NITROGEN FEED USING BULK CATALYST - Methods are provided for hydrotreating high nitrogen feeds with improved results for nitrogen removal, aromatic saturation, and/or sulfur removal. The method includes hydrotreating the feed with a supported hydrotreating catalyst followed by a bulk metal catalyst, the hydrotreated effluent of which can be suitable for use as a feed to an FCC reactor. | 02-20-2014 |
20140291202 | PRODUCTION OF LOW CLOUD POINT DISTILLATE FUELS - Methods are provided for dewaxing a distillate fuel boiling range feed to improve one or more cold flow properties of the distillate fuel feed, such as cloud point, with reduced consumption of hydrogen during the dewaxing process. The reduced hydrogen consumption is achieved by using a dewaxing catalyst with a reduced content of hydrogenation metals, such as a content of Pt or Pd of from about 0.03 wt % to about 0.35 wt %. A distillate fuel feed can be dewaxed to achieve a desired cloud point differential using a reduced metals content dewaxing catalyst under the same or similar conditions to those required for a dewaxing catalyst with higher metals content. | 10-02-2014 |
Patent application number | Description | Published |
20090261015 | Production of high viscosity index lube base oils - The invention below shows a preferred method to make high quality base oil at unexpectedly high yields using a combination of hydrotreatment of high waxy feedstocks accompanied by hydroisomerization of the resulting wax to produce an extra high VI lube of greater than 140VI and at least −18 deg C. pour point or less. The preferred combinations of conditions identified below can surprisingly lead to unexpectedly high yields. This allows the use of higher oil content (or lower wax content) feedstocks. | 10-22-2009 |
20100187156 | Sour service hydroprocessing for lubricant base oil production - An integrated process for producing lubricant base oils from feedstocks under sour conditions is provided. The ability to process feedstocks under higher sulfur conditions allows for reduced cost processing and increases the flexibility in selecting a suitable feedstock. The sour feed can be delivered to a catalytic dewaxing step without any separation of sulfur and nitrogen contaminants, or a high pressure separation can be used to partially eliminate contaminants. | 07-29-2010 |
20110180453 | Catalytic Dewaxing Process - In a catalytic dewaxing process, a catalyst comprising from 40 to 80 wt % of ZSM-48 having a silica to alumina molar ratio of less than 200:1 and from 0.3 to 1.5 wt % of a metal or metal compound from Groups 8 to 10 of the Periodic Table of the Elements is provided in a reaction zone. The catalyst is periodically contacted in the reaction zone under dewaxing conditions with a first hydrocarbon feedstock having a wax content of less than 50 wt % and with a second hydrocarbon feedstock having a wax content of 50 wt % or more. | 07-28-2011 |
20130118952 | PRETREATMENT OF FCC NAPHTHAS AND SELECTIVE HYDROTREATING - This invention provides methods for multi-stage hydroprocessing treatment of FCC naphthas for improving the overall production quantity of naphtha boiling-range materials during naphtha production for low sulfur gasolines. Of particular benefit of the present processes is the selective treating of cat naphthas to remove gums instead of undercutting the overall naphtha pool by lowering the end cutpoints of the cat naphtha fraction. This maximizes the amount of refinery cat naphtha that can be directed to the gasoline blending pool while eliminating existing processing problems in hydrodesulfurization units. The processes disclosed herein have the additional benefit of minimizing octane losses in the increased naphtha pool volume. | 05-16-2013 |
20130341243 | HYDROCRACKING PROCESS SELECTIVE FOR IMPROVED DISTILLATE AND IMPROVED LUBE YIELD AND PROPERTIES - This invention relates to a process involving hydrocracking of a feedstream in which a converted fraction can exhibit relatively high distillate product yields and maintained or improved distillate fuel properties, while an unconverted fraction can exhibit improved properties particularly useful in the lubricant area. In this hydrocracking process, it can be advantageous for the yield of converted/unconverted product for gasoline fuel application to be reduced or minimized, relative to converted distillate fuel and unconverted lubricant. Catalysts and conditions can be chosen to assist in attaining, or to optimize, desirable product yields and/or properties. | 12-26-2013 |
20150122701 | PRODUCTION OF LOW CLOUD POINT DIESEL FUELS AND LOW FREEZE POINT JET FUELS - Methods are provided for dewaxing a distillate fuel boiling range feed to improve one or more cold flow properties of the distillate fuel feed, such as cloud point, where the distillate fuel feed is fractionated to produce both a jet fuel product and an arctic diesel fuel product. The decrease of cloud point is achieved by using a feedstock having a concentration of nitrogen of less than about 50 wppm and a concentration of sulfur of less than about 15 wppm. Further, the dewaxing catalyst may have a reduced content of hydrogenation metals, such as a content of Pt or Pd of from about 0.05 wt % to about 0.35 wt %. A distillate fuel feed can be dewaxed to achieve a desired cloud point differential using a reduced metals content dewaxing catalyst under the same or similar conditions to those required for a dewaxing catalyst with higher metals content. | 05-07-2015 |